⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Figure S2 from An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer model

Shyambabu Chaurasiya Hannah Valencia Zhifang Zhang Sang-In Kim Annie Yang Jianming Lu Yanghee Woo Susanne G. Warner Nicholas J. Ede Yuman Fong

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

HMGB1 staining on tumor sections

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chaurasiya et al. (2024) studied this question.

synapsesocial.com/papers/68e5858ab6db643587522b2a https://doi.org/10.1158/1535-7163.27035965.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S1 from An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer model2024
2Data from An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer model2024
3hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer2025 · 1 citations
4Figure S4 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors2025
5Figure S4 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis2025
6Supplementary Figure S5 from An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance2024
7Supplementary Figure S1 from An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance2024
8Supplementary Figure S2 from An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance2024